DNA sequence analysis of varicella-zoster virus gene 62 from subclinical infections in healthy children immunized with the Oka varicella vaccine

Vaccine

Volumn 26, Issue 44, 2008, Pages 5627-5632

  Gomi, Yasuyuki ^a   Ozaki, Takao ^b   Nishimura, Naoko ^b   Narita, Atsushi ^b   Suzuki, Michio ^b   Ahn, Jaekun ^b   Watanabe, Naoko ^b   Koyama, Norio ^b   Ushida, Hajime ^b   Yasuda, Naoko ^b   Nakane, Kazumasa ^b   Funahashi, Keiji ^b   Fuke, Isao ^a   Takamizawa, Akihisa ^a   Ishikawa, Toyokazu ^a   Yamanishi, Koichi ^c   Takahashi, Michiaki ^a  

^a The Research Foundation for Microbial Diseases of Osaka University   (Japan)

^b Aichi Prefectural Welfare Federation of Agriculture Co operative Associations Konan Kosei Hospital   (Japan)

^c NATIONAL INSTITUTE OF BIOMEDICAL INNOVATION   (Japan)

Author keywords

Gene 62; PCR; Varicella vaccine

Indexed keywords

DNA FRAGMENT; UNCLASSIFIED DRUG; VARICELLA ZOSTER VACCINE; VARICELLA ZOSTER VACCINE OKA; VIRUS DNA;

AMINO ACID SUBSTITUTION; ANTIBODY TITER; ARTICLE; CHILD; CONTROLLED STUDY; DNA SEQUENCE; GENE FREQUENCY; GENOTYPE; HUMAN; HUMAN CELL; HUMAN EXPERIMENT; IN VIVO STUDY; JAPAN; NORMAL HUMAN; PERIPHERAL BLOOD MONONUCLEAR CELL; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PROTEIN VARIANT; UNITED STATES; VARICELLA ZOSTER VIRUS; VIRUS GENE; VIRUS LOAD; VIRUS REPLICATION; VZV GENE 62;

AMINO ACID SEQUENCE; AMINO ACID SUBSTITUTION; ANTIBODIES, VIRAL; BASE SEQUENCE; CHICKENPOX; CHICKENPOX VACCINE; CHILD; HERPESVIRUS 3, HUMAN; HUMANS; IMMEDIATE-EARLY PROTEINS; IMMUNIZATION; LEUKOCYTES, MONONUCLEAR; MOLECULAR SEQUENCE DATA; POLYMERASE CHAIN REACTION; SEQUENCE ANALYSIS, DNA; TRANS-ACTIVATORS; VIRAL ENVELOPE PROTEINS; VIRUS REPLICATION;

EID: 52949143888     PISSN: 0264410X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.vaccine.2008.07.069     Document Type: Article

References (26)

1. Takahashi M., Otsuka T., Okuno Y., Asano Y., and Yazaki T. Live vaccine used to prevent the spread of varicella in children in hospital. Lancet 2 7892 (1974) 1288-1290
2. Takahashi M., Okada S., Miyagawa H., Amo K., Yoshikawa K., Asada H., et al. Enhancement of immunity against VZV by giving live varicella vaccine to the elderly assessed by VZV skin test and IAHA, gpELISA antibody assay. Vaccine 21 25-26 (2003) 3845-3853
3. Oxman M.N., Levin M.J., Johnson G.R., Schmader K.E., Straus S.E., Gelb L.D., et al. A vaccine to prevent herpes zoster and postherpetic neuralgia in older adults. N Engl J Med 352 22 (2005) 2271-2284
4. Gomi Y., Sunamachi H., Mori Y., Nagaike K., Takahashi M., and Yamanishi K. Comparison of the complete DNA sequences of the Oka varicella vaccine and its parental virus. J Virol 76 22 (2002) 11447-11459
5. Gomi Y., Imagawa T., Takahashi M., and Yamanishi K. Oka varicella vaccine is distinguishable from its parental virus in DNA sequence of open reading frame 62 and its transactivation activity. J Med Virol 61 4 (2000) 497-503
6. Gomi Y., Imagawa T., Takahashi M., and Yamanishi K. Comparison of DNA sequence and transactivation activity of open reading frame 62 of Oka varicella vaccine and its parental viruses. Arch Virol 17 Suppl. (2001) 49-56
7. Baudoux L., Defechereux P., Schoonbroodt S., Merville M.P., Rentier B., and Piette J. Mutational analysis of varicella-zoster virus major immediate-early protein IE62. Nucleic Acids Res 23 8 (1995) 1341-1349
8. Perera L.P., Mosca J.D., Sadeghi-Zadeh M., Ruyechan W.T., and Hay J. The varicella-zoster virus immediate early protein, IE62, can positively regulate its cognate promoter. Virology 191 1 (1992) 346-354
9. Moriuchi M., Moriuchi H., Straus S.E., and Cohen J.I. Varicella-zoster virus (VZV) virion-associated transactivator open reading frame 62 protein enhances the infectivity of VZV DNA. Virology 200 1 (1994) 297-300
10. Quinlivan M.L., Gershon A.A., Al Bassam M.M., Steinberg S.P., LaRussa P., Nichols R.A., et al. Natural selection for rash-forming genotypes of the varicella-zoster vaccine virus detected within immunized human hosts. Proc Natl Acad Sci U S A 104 1 (2007) 208-212
11. Mori C., Takahara R., Toriyama T., Nagai T., Takahashi M., and Yamanishi K. Identification of the Oka strain of the live attenuated varicella vaccine from other clinical isolates by molecular epidemiologic analysis. J Infect Dis 178 1 (1998) 35-38
12. Wasmuth E.H., and Miller W.J. Sensitive enzyme-linked immunosorbent assay for antibody to varicella-zoster virus using purified VZV glycoprotein antigen. J Med Virol 32 3 (1990) 189-193
13. Quinlivan M.L., Gershon A.A., Steinberg S.P., and Breuer J. Rashes occurring after immunization with a mixture of viruses in the Oka vaccine are derived from single clones of virus. J Infect Dis 190 4 (2004) 793-796
14. Loparev V.N., Rubtcova E., Seward J.F., Levin M.J., and Schmid D.S. DNA sequence variability in isolates recovered from patients with postvaccination rash or herpes zoster caused by Oka varicella vaccine. J Infect Dis 195 4 (2007) 502-510
15. de Jong M.D., Weel J.F., Schuurman T., Wertheim-van Dillen P.M., and Boom R. Quantitation of varicella-zoster virus DNA in whole blood, plasma, and serum by PCR and electrochemiluminescence. J Clin Microbiol 38 7 (2000) 2568-2573
16. Ozaki T., Kajita Y., Asano Y., Aono T., and Yamanishi K. Detection of varicella-zoster virus DNA in blood of children with varicella. J Med Virol 44 3 (1994) 263-265
17. Cohrs R.J., Gilden D.H., Gomi Y., Yamanishi K., and Cohen J.I. Comparison of virus transcription during lytic infection of the Oka parental and vaccine strains of Varicella-Zoster virus. J Virol 80 5 (2006) 2076-2082
18. Shiraki K., Yoshida Y., Asano Y., Yamanishi K., and Takahashi M. Pathogenetic tropism of varicella-zoster virus to primary human hepatocytes and attenuating tropism of Oka varicella vaccine strain to neonatal dermal fibroblasts. J Infect Dis 188 12 (2003) 1875-1877
19. Quinlivan M.A., Gershon A.A., Nichols R.A., La Russa P., Steinberg S.P., and Breuer J. Vaccine Oka varicella-zoster virus genotypes are monomorphic in single vesicles and polymorphic in respiratory tract secretions. J Infect Dis 193 7 (2006) 927-930
20. Nagaike K., Mori Y., Gomi Y., Yoshii H., Takahashi M., Wagner M., et al. Cloning of the varicella-zoster virus genome as an infectious bacterial artificial chromosome in Escherichia coli. Vaccine 22 29-30 (2004) 4069-4074
21. Yoshii H., Somboonthum P., Takahashi M., Yamanishi K., and Mori Y. Cloning of full length genome of varicella-zoster virus vaccine strain into a bacterial artificial chromosome and reconstitution of infectious virus. Vaccine 25 27 (2007) 5006-5012
22. Somboonthum P., Yoshii H., Okamoto S., Koike M., Gomi Y., Uchiyama Y., et al. Generation of a recombinant Oka varicella vaccine expressing mumps virus hemagglutinin-neuraminidase protein as a polyvalent live vaccine. Vaccine 25 52 (2007) 8741-8755
23. Yoshii H., Sadaoka K., Matsuura M., Nagaike K., Takahashi M., Yamanishi K., et al. Varicella-zoster virus ORF 58 gene is dispensable for viral replication in cell culture. Virol J 5 (2008) 54
24. Sadaoka T., Yoshii H., Imazawa T., Yamanishi K., and Mori Y. Deletion in open reading frame 49 of varicella-zoster virus reduces virus growth in human malignant melanoma cells but not in human embryonic fibroblasts. J Virol 81 22 (2007) 12654-12665
25. Yamagishi Y., Sadaoka T., Yoshii H., Somboonthum P., Imazawa T., Nagaike K., et al. Varicella-zoster virus glycoprotein M homolog is glycosylated, is expressed on the viral envelope, and functions in virus cell-to-cell spread. J Virol 82 2 (2008) 795-804
26. Davison A.J., and Scott J.E. The complete DNA sequence of varicella-zoster virus. J Gen Virol 67 Pt 9 (1986) 1759-1816